Clinical features and outcomes of bacteremia caused by Enterococcus casseliflavus and Enterococcus gallinarum:: Analysis of 56 cases

被引:66
作者
Choi, SH
Lee, SO
Kim, TH
Chung, JW
Choo, EJ
Kwak, YG
Kim, MN
Kim, YS
Woo, JH
Ryu, J
Kim, NJ
机构
[1] Univ Ulsan, Coll Med, Asan Med Ctr, Div Infect Dis, Seoul 138736, South Korea
[2] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Lab Med, Seoul 138736, South Korea
[3] Univ Ulsan, Ctr Antimicrobial Resistance & Microbial Genet, Seoul, South Korea
关键词
D O I
10.1086/380452
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The clinical significance and virulence potential of Enterococcus casseliflavus/ flavescens and Enterococcus gallinarum are still uncertain. We retrospectively analyzed 56 cases of significant bacteremia caused by E. casseliflavus or E. gallinarum. Of these cases, 25 ( 44.6%) were associated with polymicrobial bacteremia, and 43 ( 76.8%) were associated with entry via the biliary tract. Resistance to vancomycin was observed in 17 ( 30.4%) of these 56 patients, and this resistance was significantly associated with E. gallinarum bacteremia ( adjusted odds ratio [ AOR], 10.56; 95% confidence interval [ CI], 2.41 - 46.27) and bacteremia without biliary tract origin ( AOR, 6.74; 95% CI, 1.44 - 31.67). The crude mortality rate was 13%, and the bacteremia- related mortality rate was 1.9%. In conclusion, bacteremia due to E. casseliflavus and E. gallinarum is commonly associated with biliary tract disease and may be associated with a low risk of mortality.
引用
收藏
页码:53 / 61
页数:9
相关论文
共 55 条
[11]   EMERGENCE OF HIGH-LEVEL RESISTANCE TO GLYCOPEPTIDES IN ENTEROCOCCUS-GALLINARUM AND ENTEROCOCCUS-CASSELIFLAVUS [J].
DUTKAMALEN, S ;
BLAIMONT, B ;
WAUTERS, G ;
COURVALIN, P .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1994, 38 (07) :1675-1677
[12]   DETECTION OF GLYCOPEPTIDE RESISTANCE GENOTYPES AND IDENTIFICATION TO THE SPECIES LEVEL OF CLINICALLY RELEVANT ENTEROCOCCI BY PCR [J].
DUTKAMALEN, S ;
EVERS, S ;
COURVALIN, P .
JOURNAL OF CLINICAL MICROBIOLOGY, 1995, 33 (01) :24-27
[13]   Effect of vancomycin on intestinal flora of patients who previously received antimicrobial therapy [J].
Edlund, C ;
Barkholt, L ;
OlssonLiljequist, B ;
Nord, CE .
CLINICAL INFECTIOUS DISEASES, 1997, 25 (03) :729-732
[14]   IDENTIFICATION OF ENTEROCOCCUS SPECIES ISOLATED FROM HUMAN INFECTIONS BY A CONVENTIONAL TEST SCHEME [J].
FACKLAM, RR ;
COLLINS, MD .
JOURNAL OF CLINICAL MICROBIOLOGY, 1989, 27 (04) :731-734
[15]   Association between resistance to vancomycin and death in cases of Enterococcus faecium bacteremia [J].
Garbutt, JM ;
Ventrapragada, M ;
Littenberg, B ;
Mundy, LM .
CLINICAL INFECTIOUS DISEASES, 2000, 30 (03) :466-472
[16]   RECOVERY OF VANCOMYCIN-RESISTANT GRAM-POSITIVE COCCI FROM PEDIATRIC LIVER-TRANSPLANT RECIPIENTS [J].
GREEN, M ;
BARBADORA, K ;
MICHAELS, M .
JOURNAL OF CLINICAL MICROBIOLOGY, 1991, 29 (11) :2503-2506
[17]   Revised approach for identification and detection of ampicillin and vancomycin resistance in Enterococcus species by using MicroScan panels [J].
Iwen, PC ;
Kelly, DM ;
Linder, J ;
Hinrichs, SH .
JOURNAL OF CLINICAL MICROBIOLOGY, 1996, 34 (07) :1779-1783
[18]   RECOVERY OF RESISTANT ENTEROCOCCI DURING VANCOMYCIN PROPHYLAXIS [J].
KAPLAN, AH ;
GILLIGAN, PH ;
FACKLAM, RR .
JOURNAL OF CLINICAL MICROBIOLOGY, 1988, 26 (06) :1216-1218
[19]   Is vancomycin resistance in enterococci predictive of inferior outcome of enterococcal bacteremia? [J].
Krcmery, V ;
Bilíková, E ;
Svetlansky, I ;
Kovacicová, G .
CLINICAL INFECTIOUS DISEASES, 2001, 32 (07) :1110-1112
[20]   Enterococcal bacteremia: Risk factors for vancomycin resistance and predictors of mortality [J].
Lautenbach, E ;
Bilker, WB ;
Brennan, PJ .
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 1999, 20 (05) :318-323